Alternate Health AAQS
The The AAQS of Alternate Health (AHGIF) as of Nov 19, 2026 is 1. In the previous year, The AAQS was 1.00 — a change of 0.00% (lower).
Get this data via API
Financial Data API
AAQS
1
YoY
0.00%
Last updated:
Alternate Health has a current AAQS of 1.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Alternate Health in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Alternate Health in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
The Alternate Health AAQS history
3 Years
10 Years
25 Years
Max
AAQS
Date
AAQS
Jan 1, 2016
1.00 CAD
Jan 1, 2017
1.00 CAD
Jan 1, 2018
1.00 CAD
| YEAR | AAQS | YoY |
|---|---|---|
| 1 | 0.00% | |
| 1 | 0.00% | |
| 1 | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Alternate Health Stock analysis
What does Alternate Health do? Alternate Health Corp. generates revenue through the manufacturing and distribution of pharmaceutical grade cannabis products across the United States. The company offers a range of products including topical creams, tinctures, and Hempnesic, a hemp-based pain management cream, targeting patients seeking treatment for pain, scars, and fungus. Its subsidiaries provide medical practice management software, clinical research services, and continuing education programs, while its software systems support CBD product distribution, hemp-derived extract manufacturing, blockchain tax collection, and electronic medical records (EMR) platforms.
The firm's primary customers are patients requiring medical cannabis solutions, healthcare providers utilizing its management software, and institutions participating in clinical research and education programs. Through its diversified operations, Alternate Health Corp. serves both the consumer market for cannabis-based treatments and the healthcare sector for technology-driven patient care and research.
Alternate Health Corp. leverages its subsidiaries, Alternate Health, Inc. and Alternate Health USA Inc., to expand its product offerings and operational reach. The company's revenue streams include direct sales of cannabis products, software licensing for medical practice management, and service-based income from clinical research and education programs. Alternate Health is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Alternate Health stock
The AAQS of Alternate Health is 1 in 2018.
On Eulerpool you can find the complete historical development of The AAQS Alternate Health since 2006 – with annual values, charts, and detailed analysis.
The AAQS is a key figure developed by AlleAktien.
The AAQS is a key figure developed by AlleAktien.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Quality — Alternate Health
All Key Metrics — Alternate Health
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth